Ignyta Stock Price (NASDAQ:RXDX)

Add to My Stocks
$26.95 $0 (0%) RXDX stock closing price Feb 08, 2018 (Closing)
Prev Close* : $26.95
Market Cap:
Day Low: $0
52 Week Low: $5.70
Open: $0
Volume: -
Day High: $0
52 Week High: $27.10

Latest Stock Market News

Latest Articles

Ignyta News - From Partners

Company News For Dec 26, 2017   by Zacks on Dec 26, 2017

RXDX Stockcharts

View RXDX PE ratio, PS ratio stocks charts and compare with peers.
RXDX Chart
Note: Compare Ignyta stock price history with the index and industry peers.

Ignyta Valuation

PE ratio
(price earnings ratio)
PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Ignyta Returns

(return on equity)

Ignyta Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity
Dividend Yield

RXDX Industry Peers

Company Price Change (%)
Portola Pharma (PTLA)28.260.14 (0.49%)
Tesaro Inc (TSRO)35.770.73 (2.08%)
Stemline Therapeutics (STML)17.230.18 (1.06%)
Blueprint Medicines (BPMC)70.962.29 (3.33%)
Endocyte (ECYT)17.970.51 (2.92%)
Eli Lilly (LLY)106.881.17 (1.11%)
Pfizer (PFE)43.510.5 (1.16%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
ChemoCentryx (CCXI)11.521.03 (9.82%)
AcelRx Pharma (ACRX)3.750.3 (8.7%)
MELINTA THERAPT (MLNT)4.450.35 (8.54%)
Galectin Therapeutics (GALT)6.020.28 (4.88%)
GlycoMimetics (GLYC)14.580.67 (4.82%)
Achaogen (AKAO)4.280.17 (4.14%)
Concert Pharma (CNCE)13.420.51 (3.95%)
Top gainers from Medical-Drugs industry
* As of Sep 19, 2018
CompanyPriceChange (%)
MADRIGAL PHARMA (MDGL)207.321.13 (9.25%)
Tetraphase Pharmaceuticals (TTPH)2.90.16 (5.23%)
Recro Pharma (REPH)7.410.29 (3.77%)
Corcept Therapeutics (CORT)14.260.48 (3.26%)
Lannett Co (LCI)4.750.15 (3.06%)
Catalyst Pharma (CPRX)3.10.09 (2.82%)
Galmed Pharma (GLMD)12.610.24 (1.87%)
Top losers from Medical-Drugs industry
* As of Sep 19, 2018

Ignyta Inc Stock News - Partner Headlines

Ignyta Financial Statements

income statement20162015201420132012
Net Sales or Revenues-----
Net Income-103.63M-92.45M-39.98M-14.21M-1.27M
Total Operating Expense100.67M90.57M39.99M13.9M0
View Ignyta income statement
balance sheet20162015201420132012
Total Assets144.91M196.14M85.3M53.31M5.44M
Total Liabilities50.14M60.16M29.35M11.53M-
Shareholders Equity94.77M135.98M55.94M41.78M4.56M
View Ignyta balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-7.08M3.43M--
Net Cash from (used by) Operating Activities-90.11M-50.8M-32.48M-13.07M-0.99M
Increase (Decrease) in Prop Plant And Equipment-2.37M-3.52M-3.1M-0.67M-0.3M
View Ignyta cash flow statement

Ignyta Stock Message Board

As of last trading day, Ignyta stock price was $26.95. The total market value as denoted by $1.82B for Ignyta, is the market value of the company's outstanding shares. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Ignyta stock analysis.

Demand for a stock decides its stock market price. For example, if more investors want to buy RXDX stock than sell it, then Ignyta stock price goes up. Conversely, if more investors wanted to sell RXDX stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume of shares traded stood at 254,655 on the last trading day, as is evident from Ignyta stock chart, and RXDX stock quote data. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Ignyta dividend per share was 0.00 during the last quarter. One can observe stock price trends and check for volatility by checking Ignyta stock price history.